Chandra Bhagat Pharma Ltd

Chandra Bhagat Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Chandra Bhagat Pharma Ltd

₹ 48.1 0.10%
04 Sep - close price
cbcpharma.com BSE - SME: 542934
About

Incorporated in 2003, Chandra Bhagat Pharma Ltd manufactures and trades Pharmaceutical Formulations and API Products[1]

Key Points

Business Overview:[1][2]
Company manufactures formulations and does trading of API in domestic and international markets through its own distribution network and Sales force, under the brand name CBC.
It manufactures formulations by outsourcing to third party on job work basis
a) Major focus on Injection viz. ITV (Intravenous) & IM (Intramuscular), tablets and capsules supply to Hospital and Health care Centre for critical diseases
b) Getting approved formulations manufactured through Contract Manufacturers, Source & Supply of Generic and branded Pharma formulations and medicines to healthcare institution, Government, NGO’s, Hospitals & Distributors
c) Source, deal in Import, indenting and Supply in Specialty Chemicals, Intermediates & Active Pharmaceuticals Ingredients (API)

Website BSE
  • Market Cap ₹ 36.3 Cr.
  • Current Price ₹ 48.1
  • High / Low ₹ 80.0 / 0.00
  • Stock P/E 42.2
  • Book Value ₹ 39.7
  • Dividend Yield 0.00 %
  • ROCE 6.48 %
  • ROE 2.92 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Promoter holding has increased by 1.91% over last quarter.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -1.59% over past five years.
  • Company has a low return on equity of 3.89% over last 3 years.
  • Earnings include an other income of Rs.5.52 Cr.
  • Company has high debtors of 151 days.
  • Working capital days have increased from 75.6 days to 116 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2020 Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025
22.36 48.33 43.15 50.93 44.27 75.40 119.26 102.11 64.92 21.80
20.71 46.67 41.53 49.87 43.24 73.60 124.26 104.15 66.11 22.06
Operating Profit 1.65 1.66 1.62 1.06 1.03 1.80 -5.00 -2.04 -1.19 -0.26
OPM % 7.38% 3.43% 3.75% 2.08% 2.33% 2.39% -4.19% -2.00% -1.83% -1.19%
0.02 0.46 0.47 1.15 0.60 0.19 7.01 4.32 3.07 2.45
Interest 1.62 1.86 1.45 1.63 1.04 1.15 0.66 0.73 0.85 1.10
Depreciation 0.01 0.02 0.06 0.06 0.05 0.22 0.43 0.21 0.41 0.54
Profit before tax 0.04 0.24 0.58 0.52 0.54 0.62 0.92 1.34 0.62 0.55
Tax % 25.00% 33.33% 24.14% 30.77% 31.48% 14.52% 31.52% 33.58% -11.29% 69.09%
0.03 0.16 0.43 0.36 0.37 0.54 0.63 0.90 0.68 0.17
EPS in Rs 0.04 0.21 0.57 0.48 0.49 0.72 0.83 1.19 0.90 0.23
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
48.01 61.13 79.84 89.79 97.06 106.28 93.97 70.70 94.04 119.67 221.37 86.72
46.18 58.13 76.42 85.41 92.47 101.69 90.85 67.02 91.20 116.33 228.41 88.17
Operating Profit 1.83 3.00 3.42 4.38 4.59 4.59 3.12 3.68 2.84 3.34 -7.04 -1.45
OPM % 3.81% 4.91% 4.28% 4.88% 4.73% 4.32% 3.32% 5.21% 3.02% 2.79% -3.18% -1.67%
0.64 0.31 0.38 0.49 0.67 0.44 0.44 0.48 1.62 0.29 11.33 5.52
Interest 1.88 2.35 2.83 3.81 3.67 4.09 3.11 3.76 3.24 2.20 1.39 1.95
Depreciation 0.17 0.26 0.24 0.14 0.06 0.05 0.03 0.12 0.12 0.27 0.64 0.95
Profit before tax 0.42 0.70 0.73 0.92 1.53 0.89 0.42 0.28 1.10 1.16 2.26 1.17
Tax % 16.67% 38.57% 50.68% 27.17% 32.68% 22.47% 26.19% 32.14% 27.27% 21.55% 32.74% 26.50%
0.35 0.43 0.35 0.66 1.03 0.69 0.31 0.19 0.80 0.91 1.53 0.86
EPS in Rs 8.37 10.29 8.37 15.79 24.64 10.29 0.41 0.25 1.06 1.21 2.03 1.14
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 4%
5 Years: -2%
3 Years: -3%
TTM: -61%
Compounded Profit Growth
10 Years: 7%
5 Years: 23%
3 Years: 2%
TTM: -44%
Stock Price CAGR
10 Years: %
5 Years: 4%
3 Years: -23%
1 Year: -36%
Return on Equity
10 Years: 4%
5 Years: 3%
3 Years: 4%
Last Year: 3%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.42 0.42 0.42 0.42 0.42 0.67 7.55 7.55 7.55 7.55 7.55 7.55
Reserves 5.55 5.98 6.33 6.99 8.03 13.78 18.14 18.33 19.13 19.93 21.46 22.42
18.58 27.50 27.83 22.08 21.75 31.22 29.93 27.07 21.11 18.94 16.43 20.86
7.07 8.39 9.91 26.40 27.86 37.19 19.12 18.83 24.68 14.16 56.37 50.70
Total Liabilities 31.62 42.29 44.49 55.89 58.06 82.86 74.74 71.78 72.47 60.58 101.81 101.53
1.02 0.87 0.69 0.55 0.51 0.46 0.44 0.42 0.47 0.73 2.52 2.62
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 4.64 1.05 4.03 0.75 0.00 0.22 0.11 0.13 0.14
30.60 41.42 43.80 50.70 56.50 78.37 73.55 71.36 71.78 59.74 99.16 98.77
Total Assets 31.62 42.29 44.49 55.89 58.06 82.86 74.74 71.78 72.47 60.58 101.81 101.53

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.00 0.00 0.00 -9.03 -6.18 4.05 -7.41 8.33 12.40 5.26 6.18 -5.71
0.00 0.00 0.00 0.30 -0.36 -0.40 0.05 0.12 0.09 -0.06 -1.85 -0.78
0.00 0.00 0.00 7.97 6.51 -3.73 6.94 -6.42 -9.62 -4.45 -5.80 2.19
Net Cash Flow 0.00 0.00 0.00 -0.75 -0.02 -0.08 -0.43 2.02 2.86 0.76 -1.48 -4.30

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 65.15 70.99 66.15 79.92 67.16 90.32 54.50 79.61 58.22 24.98 65.05 151.31
Inventory Days 161.44 176.71 122.83 132.66 144.60 173.53 186.75 214.70 153.25 99.59 15.23 3.44
Days Payable 53.01 43.18 32.81 80.69 68.58 117.37 53.13 78.51 11.98 10.62 23.21 44.58
Cash Conversion Cycle 173.59 204.52 156.17 131.89 143.18 146.48 188.12 215.80 199.49 113.95 57.06 110.17
Working Capital Days 148.78 166.47 133.63 124.96 138.50 83.39 147.60 177.18 103.94 75.00 35.89 115.87
ROCE % 11.68% 10.44% 10.40% 14.77% 17.42% 13.13% 6.97% 7.44% 8.62% 7.13% 7.95% 6.48%

Shareholding Pattern

Numbers in percentages

1 Recently
Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025
70.42% 70.42% 71.80% 71.80% 70.11% 69.09% 68.24% 68.69% 68.77% 69.29% 71.20%
0.00% 0.00% 0.00% 0.00% 0.00% 0.85% 0.85% 1.33% 1.33% 0.48% 0.61%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.89% 0.89% 0.00% 0.00%
29.58% 29.58% 28.20% 28.20% 29.89% 30.07% 30.91% 29.09% 29.02% 30.23% 28.18%
No. of Shareholders 17815610690126126146134152315316

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings